LBW-242

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLBW-242
Drug Alias NameNVP-LBW242second mitochondria-derived activator of caspases mimetics (cancer), NovartisLBW-242NVP-LBW242
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsCellular inhibitor of apoptosis protein 1 inhibitorsDiablo homolog, mitochondrial stimulants
TargetsCellular inhibitor of apoptosis protein 1Diablo homolog, mitochondrial
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Ag
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A